| Death | Reoperation | ||
---|---|---|---|---|
Hazard Ratio (95% CI) | P-value | Hazard Ratio (95% CI) | P-value | |
Male gender | 1.07 (0.92–1.24) | 0.360 | 1.56 (0.91–2.66) | 0.107 |
Age groupa | ||||
 65–70 | 1.0 |  | 1.0 |  |
  < 50 | 1.35 (0.55–3.33) | 0.516 | 5.61 (1.59–19.8) | 0.007* |
 50–65 | 1.05 (0.74–1.51) | 0.77 | 2.44 (1.17–5.08) | 0.017* |
 70–80 | 1.81 (1.43–2.28) | < 0.001* | 0.71 (0.37–1.38) | 0.312 |
  ≥ 80 | 3.19 (2.46–4.12) | < 0.001* | 0.60 (0.21–1.70) | 0.337 |
Reoperationb | 1.06 (0.74–1.52) | 0.747 |  |  |
Valve size | ||||
 25 | 1.0 |  | 1.0 |  |
 19–23 | 1.22 (1.03–1.45) | 0.025* | 0.73 (0.42–1.26) | 0.252 |
 27–29 | 0.94 (0.71–1.25) | 0.658 | 1.03 (0.45–2.34) | 0.948 |
Diabetes Mellitus | 1.22 (0.99–1.51) | 0.067* | 1.38 (0.68–2.81) | 0.369 |
Smoker | 1.59 (1.29–1.97) | < 0.001* | 1.61 (0.74–3.52) | 0.234 |
Previous smoker | 1.08 (0.91–1.28) | 0.383 | 1.39 (0.77–2.51) | 0.269 |
VP-PM | 1.18 (0.95–1.48) | 0.144 | 2.19 (1.21–3.98) | 0.010* |
EuroSCORE II < 4% | 0.61 (0.43–0.87) | 0.006* | 0.12 (0.06–0.22) | < 0.001* |
Hypertension treatment | 1.01 (0.87–1.17) | 0.889 | 0.98 (0.59–1.64) | 0.945 |
Lipid-lowering treatmentc | 0.68 (0.58–0.80) | < 0.001* | 1.09 (0.61–1.96) | 0.759 |